Biotech ETF Channel

Despite a sell-off in stocks, investors kept adding to their ETF holdings. 

Investors added another $16 billion to U.S.-listed ETFs, bringing year-to-date inflows up to $89.1 billion.

Plus, the challenges and risks that come with factor strategies.

The volatile segment struggled to catch a break, then rallied, and now sits in the limelight of a virus outbreak.

Sector ETFs had a great month, with most seeing positive returns.

Also, ETFs versus index funds: which to use?

Also, what the Schwab-TDA deal means for small advisors.

A few sector ETFs faltered during the month